"I love Carragelose :: Carragelose"

2022-06-10 18:11:14

Portfolio Common cold products Launched products Mode of Action Business Development FAQ Publications Contact © 2022 Marinomed Biotech AG Carragelose® The antiviral polymer from red seaweed The polymer Carragelose® is a unique broadly active anti-viral compound for treating respiratory diseases. It has been approved for marketing in the EU, parts of Asia and Australia as part of nasal sprays, throat sprays and lozenges. Carragelose® is a sulfated polymer from red seaweed also widely used in the food industry and has GRAS status (FDA). The compound has a broad spectrum of anti-viral properties and is protected by a strong patent family. New in vitro data show the virus neutralising effect of Carragelose® on SARS-CoV-2 more info Portfolio Nasal Sprays Throat Sprays Lozenges Learn more Mode of Action A cold comes three days – stays three days – leaves three days. Colds are caused by more than 200 different respiratory viruses. Like a burr to textiles, cold viruses bind to the surfaces of the upper respiratory tract. Then the infection starts. It is time to interfere! Sprayed into the nose Carragelose® creates a protective layer in the nasal cavity that helps to reduce the spreading and proliferation of the common cold virus. The clotted viruses leave the body via the natural route – the cold might not even come, stay shorter or leave faster. No virus – no cold – naturally achieved. Learn more Safety and Efficacy The safety and anti-viral effectiveness of Carragelose® have been established in several clinical and non-clinical trials. Three double-blind, placebo-controlled clinical trials confirmed the anti-viral effectiveness, a significant reduction of the duration of the disease, a significant reduction of viral load and a reduction of relapses. Learn more Portfolio Common cold products Launched products Mode of Action Business Development FAQ Publications Marinomed Biotech AGHovengasse 252100 Korneuburg, Austria+43 2262 90300 [email protected] © 2022 Marinomed Biotech AG Contact Privacy Policy Legal notice produced by IXOLIT / crossconnect By visiting our website, you consent to our use of cookies to enhance your browsing experience. Further information on data protection is provided in our data protection declaration. I agree